Study Confirms Anti-Infective ARIKACE(TM) Effectively Penetrates Mucus And Biofilm, And Kills Pseudomonas

Transave Inc. reported that its lead product candidate, ARIKACE(TM) (liposomal amikacin for inhalation), may have the ability to penetrate mucus and biofilms, and decrease the number of Pseudomonas aeruginosa lung infections in patients with cystic fibrosis, according to results of a study published in the Journal of Antimicrobial Chemotherapy.

More: continued here

Filed under: Infectious Diseases / Bacteria / Viruses on April 2nd, 2008